We have hypothesized as such that the function of TGFB2 expression is correlated with Interferon Alpha 1 (IFN-α), possibly through Interferon Regulatory Factor 9 (IRF9) mRNA as a key factor for eliciting the tumorigenic activity of IFN-α, and other members of the STAT family, and targeting these molecules simultaneously can help find more treatment options for pancreatic cancer. This evidence concerns the gene TGFB2 and familial pancreatic carcinoma.